The Natural Products Association is hosting a 30-minute call on Oct. 1 to discuss the U.S. Food and Drug Administration’s decision that NMN is not excluded from the definition of a dietary supplement.
NPA leadership and its outside counsel will discuss what FDA’s decision means for NMN, “drug preclusion” more generally, and NPA’s pending lawsuit against FDA.
This meeting is for NPA members only. Free to register.
